查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
水膠體敷料的全球市場:市場規模 - 各原料，各用途，各產品，各終端用戶，各地區展望，競爭策略，各市場區隔預測(～2030年)
市場調查報告書
商品編碼
1139774

水膠體敷料的全球市場:市場規模 - 各原料，各用途，各產品，各終端用戶，各地區展望，競爭策略，各市場區隔預測(～2030年)

Hydrocolloid Dressing Market Size - By Raw Material, By Application, By Product, By End-User - Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球水膠體敷料的市場規模，預計至2030年達到21億2,000萬美元，以5.5％的年複合成長率成長。

先進的傷口護理使用水膠體敷料，有高耐用性，癒合速度快，減輕不舒服，降低感染風險，與周圍皮膚的緊貼性等，許多優點。還有創傷部分性癒合時，剛癒合的皮膚完好無損時，成為保護該處避免表面損傷的防護牆。由於這些優點，水膠體敷料的使用在預測期間內預計增加。

本報告提供全球水膠體敷料市場相關調查，市場動態，市場變數及預測，各原料、用途、產品、終端用戶、地區分析，企業簡介等相關資訊。

目錄

第1章 簡介

  • 調查範圍
  • 市場區隔分析

第2章 調查手法

  • 調查資料來源
  • 市場規模的估計
  • 資料的三角測量

第3章 摘要整理

第4章 市場動態

  • 促進因素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 全球水膠體敷料市場:COVID-19影響

第5章 市場變數及預測

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 全球水膠體敷料市場:各原料，2019年～2030年(100萬美元)

  • 合成
  • 天然
  • 半合成

第7章 全球水膠體敷料市場:各用途，2019年～2030年(100萬美元)

  • 壓力潰瘍
  • 靜脈性小腿潰瘍
  • 糖尿病性潰瘍
  • 燒燙傷
  • 其他

第8章 全球水膠體敷料市場:各產品，2019年～2030年(100萬美元)

  • 薄板淋醬
  • 非晶質
  • 浸漬淋醬

第9章 全球水膠體敷料市場:各終端用戶，2019年～2030年(100萬美元)

  • 居家照護環境
  • 醫院、診所
  • 其他

第10章 全球水膠體敷料市場:各地區，2019年～2030年(100萬美元)

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他的亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他的中東、非洲

第11章 企業簡介

  • B. Braun Melsungen AG
    • 企業概要
    • 財務預測
    • 產品概要
    • 最近的開發
  • Cardinal Health
  • Convatec Inc.
  • Covalon Technologies Ltd.
  • Coloplast Corp.
  • Dermarite Industries LLC.
  • Johnson & Johnson
  • Lohmann & Rausche
  • Medline Industries Inc.
  • Paul Hartmann AG
  • Smith & Nephew
  • 3M
簡介目錄
Product Code: HLCA2211

According to SPER Market Research, the Hydrocolloid Dressing Market estimated to reach USD 2.12 billion by 2030 with a CAGR of 5.5%.

Accidents frequently cause severe bleeding and other injuries, demanding immediate medical attention and surgical procedures to provide patients with relief right away. Because hydrocolloid dressings are efficient for both acute and chronic wounds of various thicknesses, the prevalence of both chronic and acute wounds is thus anticipated to increase.

In lower discharge or necrotic tissue, they promote autolytic debridement. For the treatment of pressure injuries, they adhere successfully to high-friction regions such as the heels and the sacrum. In order to reduce pressure injuries caused by medical devices, hydrocolloid dressings are also used as protective dressings on intubated patients in the ICU. Abrasions and small burns are also treated with them. The aforementioned factors are hence driving the expansion of the hydrocolloid dressing market. Due to its absorbency and ability to provide a barrier of protection over the skin, hydrocolloid technology has long been used in advanced wound care.

The use of additives and recent breakthroughs in hydrocolloid technology has considerably improved patient care. The production of materials using contemporary hydrocolloid extruders is more efficient, reliable, and waste-free. The creation of hybrid materials that mix hydrocolloid and acrylic PSA is another development in the hydrocolloid family. One such development is the exclusive Thin Absorbent Skin Adhesive from Avery Dennison Medical (TASA).

A variety of carrier materials, including polyurethane films and nonwovens, can be coated with adhesive. Standard hydrocolloid adhesives typically range in thickness from 0.3 to 1.0 mm, but TASA is only 0.1 mm thick. Additionally, it encourages absorbency and breathability. Wear periods of up to seven days are possible because of these exceptional fluid-handling characteristics. As a result, these improvements and advancements have created a wide range of new opportunities for a better patient experience, boosting the industry. Using a hydrocolloid dressing for advanced wound care has a number of additional benefits, such as high durability, quicker healing, reduced discomfort, a lower risk of infection, and adherence exclusively to surrounding skin. In addition, hydrocolloids are inexpensive, versatile, and waterproof. When wounds are partially healed or newly healed skin is still intact, they can make an excellent protective barrier to shield the area from potential surface harm. Because of the mentioned advantages offered by hydrocolloid dressings, their use is therefore expected to increase during the projection period.

Impact of COVID-19 on the Global Hydrocolloid Dressing Market:

Doctors and other front-line personnel have greatly benefited from the hydrocolloid dressing's ability to avoid facial pressure and facial markings when wearing medical protective equipment during the COVID-19 epidemic. A layer of semi-permeable hydrocolloid, commonly used for wound healing, can be found inside a film or foam pad that clings to the skin. This is accomplished by using a hydrocolloid dressing. Following the trimming of the hydrocolloid dressing, the adhesive dressing is applied to the skin of the nasal dorsum, cheeks, and forehead, covering the region where the mask and safety goggles would sit. This has a substantial impact on the market expansion of hydrocolloids in the pharmaceutical industry.

Scope of the report

Report Metric Details:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Raw Material, By Application, By Product, By End-User
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
  • Companies Covered: B. Braun Melsungen AG, Cardinal Health, Convatec Inc., Covalon Technologies Ltd., Coloplast Corp., Dermarite Industries LLC., Johnson & Johnson, Lohmann & Rauscher, Medline Industries Inc., Paul Hartmann AG, Smith & Nephew, 3M.

Global Hydrocolloid Dressing Market, By Raw Material:

Based on the Raw Material, Global Hydrocolloid Dressing Market is segmented as; Synthetic, Natural, Semi-Synthetic.

Global Hydrocolloid Dressing Market, By Application:

Based on the Application, Global Hydrocolloid Dressing Market is segmented as; Pressure Ulcer, Venous leg Ulcer, Diabetic Ulcer, Burn Wounds, Others.

Global Hydrocolloid Dressing Market, By Product:

Based on the Product, Global Hydrocolloid Dressing Market is segmented as; Sheet Dressings, Amorphous, Impregnated Dressings.

Global Hydrocolloid Dressing Market, By End-User:

Based on the End-User, Global Hydrocolloid Dressing Market is segmented as; Homecare Settings, Hospitals & Clinics, Others.

Global Hydrocolloid Dressing Market, By Regions:

The Global Hydrocolloid Dressing Market is majorly driven by North-America. During the projected period, North-America is anticipated to have the quickest rate of growth in the worldwide Hydrocolloid Dressing Market.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Hydrocolloid Dressing Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Hydrocolloid Dressing Market , By Raw Material, 2019-2030 (USD Million)

  • 6.1. Synthetic
  • 6.2. Natural
  • 6.3. Semi-Synthetic

7. Global Hydrocolloid Dressing Market , By Application, 2019-2030 (USD Million)

  • 7.1. Pressure Ulcer
  • 7.2. Venous leg Ulcer
  • 7.3. Diabetic Ulcer
  • 7.4. Burn Wounds
  • 7.5. Others

8. Global Hydrocolloid Dressing Market , By Product, 2019-2030 (USD Million)

  • 8.1. Sheet Dressings
  • 8.2. Amorphous
  • 8.3. Impregnated Dressings

9. Global Hydrocolloid Dressing Market , By End-User, 2019-2030 (USD Million)

  • 9.1. Homecare Settings
  • 9.2. Hospitals & Clinics
  • 9.3. Others

10. Global Hydrocolloid Dressing Market , By Region , 2019-2030 (USD Million)

  • 10.1. North America
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Mexico
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. United Kingdom
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of Asia-Pacific
  • 10.4. South America
    • 10.4.1. Brazil
    • 10.4.2. Argentina
    • 10.4.3. Rest of South America
  • 10.5. Middle East & Africa
    • 10.5.1. Kingdom of Saudi Arabia
    • 10.5.2. United Arab Emirates
    • 10.5.3. Rest of Middle East & Africa

11. Company Profiles

  • 11.1. B. Braun Melsungen AG
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Cardinal Health
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Convatec Inc.
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Covalon Technologies Ltd.
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Coloplast Corp.
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Dermarite Industries LLC.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Johnson & Johnson
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Lohmann & Rauscher
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Medline Industries Inc.
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Paul Hartmann AG
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary
    • 11.10.4. Recent developments
  • 11.11. Smith & Nephew
    • 11.11.1. Company details
    • 11.11.2. Financial outlook
    • 11.11.3. Product summary
    • 11.11.4. Recent developments
  • 11.12. 3M
    • 11.12.1. Company details
    • 11.12.2. Financial outlook
    • 11.12.3. Product summary
    • 11.12.4. Recent developments